Target intelligence / Profile preview

MicroRNA 5192 (MIR5192)

Target
MIR5192
Molecular classification
MicroRNA, Non-coding RNA, Short regulatory RNA (miRNA class)
01

Overview

MicroRNA 5192 (MIR5192) is a human microRNA gene encoding a short (20-24 nt) non-coding regulatory RNA. Like other miRNAs, MIR5192 is transcribed by RNA polymerase II, processed from a primary transcript to a precursor hairpin, and then further processed to a mature miRNA. Mature MIR5192 is incorporated into the RNA-induced silencing complex (RISC), where it can regulate gene expression by binding complementary sequences in target mRNAs, leading to translational repression or mRNA destabilization. There are currently no functional studies mapping specific targets, disease associations, or therapeutic relevance for MIR5192 itself. Its classification, roles, and mechanisms are inferred from general miRNA biology. Summary: MIR5192 is a human microRNA gene; it is not a receptor, enzyme, or classical drug target, and there is no evidence for direct pathogenic, biomarker, or therapeutic roles as of the latest sources.

Other names
hsa-mir-5192MIR5192MicroRNA 5192GC02U902488 (previous GeneCards identifier)GC02P062434 (previous GeneCards identifier)
02

Mechanism of action

Not applicable; MIR5192 is not a recognized drug target. For miRNAs generally, mechanisms include translational repression, mRNA destabilization, and cleavage

03

Biological functions

Post-transcriptional regulation of gene expressionTranslational inhibition of target mRNAsmRNA destabilizationMay participate in cell differentiation, proliferation, or survival, inferred from general miRNA roles
04

Disease associations

None specific to MIR5192 known. For miRNAs in general: implicated in cancer, cardiovascular disease, inflammation, and other conditions, but no direct evidence for MIR5192
05

Safety considerations

Not applicable; there are no known therapeutic interventions targeting MIR5192, thus no documented safety concerns
06

Interacting drugs

None reported in curated databases or primary literature for MIR5192
07

Biomarkers

No reported clinical biomarkers using or targeting MIR5192. Some miRNAs (not MIR5192) are used as biomarkers in disease diagnosis and prognosis

Beyond the preview

Go deeper on MicroRNA 5192 (MIR5192).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MicroRNA 5192 (MIR5192).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call